Literature DB >> 21902722

Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.

Rhayany de Castro Ribeiro Lindenblatt1, Gisele Lago Martinez, Licínio Esmeraldo Silva, Paulo Silvestre Faria, Danielle Resende Camisasca, Simone de Queiroz Chaves Lourenço.   

Abstract

BACKGROUND: The TNM system has been used for decades in an attempt to predict clinical behavior and appropriate therapy for oral squamous cell carcinomas. Histopathologic classifications can be useful as an additional predictive tool. The purpose of this study was to apply four grading systems (Multiparameter Grading System, Malignancy Grading of the Deep Invasive Margins, World Health Organization grading system, and Histologic Risk Assessment) to oral squamous cell carncinomas and evaluate each system based on clinicopathologic parameters and patient survival.
METHODS: The files of 53 patients diagnosed with primary oral squamous cell carcinoma at the Brazilian National Cancer Institute were evaluated. All hematoxylin and eosin-stained slides were reviewed to confirm the original diagnosis and to determine histopathologic grading. Clinicopathologic information was obtained from medical records and tumor registries. Statistical analysis was performed using Fisher's exact test or the chi-square test, the Kaplan-Meier method, and the log-rank test.
RESULTS: The Multiparameter Grading System was statistically associated with pathologic staging (P = 0.02) and lymph node involvement (P = 0.0009). Differences in overall 5-year survival were significant for Histologic Risk Assessment (P = 0.015), pathologic staging (P = 0.001), lymph node status (P < 0.0001), and recurrence (P = 0.0001). Differences in cancer-specific 5-year survival were significant for Histologic Risk Assessment (P = 0.029), pathologic staging (P = 0.002), lymph node involvement (P < 0.0001), and recurrence (P < 0.0001). Poorly differentiated tumors were associated with the worst disease-free survival (P = 0.031) and recurrence (P = 0.043).
CONCLUSION: Of the grading systems evaluated, Histologic Risk Assessment demonstrated the best results for survival prediction in oral squamous cell carcinoma.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21902722     DOI: 10.1111/j.1600-0714.2011.01068.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  31 in total

1.  Overexpression of ADAM9 in oral squamous cell carcinoma.

Authors:  Pattaramon Tanasubsinn; Win Pa Pa Aung; Supansa Pata; Witida Laopajon; Anupong Makeudom; Thanapat Sastraruji; Watchara Kasinrerk; Suttichai Krisanaprakornkit
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

2.  Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front.

Authors:  Yuu Ozaki-Honda; Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Takao Ayuse; Tohru Ikeda
Journal:  Cancer Microenviron       Date:  2017-11-02

3.  Clinical study of poorly differentiated head and neck squamous cell carcinoma: a prospective cohort study in China.

Authors:  Shuo Ding; Wei Guo; Gaofei Yin; Nuan Li; Hongfei Liu; Junwei Huang; Zheng Yang; Hongbo Xu; Xiaohong Chen; Yang Zhang; Zhigang Huang
Journal:  Ann Transl Med       Date:  2022-06

4.  JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection.

Authors:  Yen-Hao Chen; Chang-Han Chen; Chih-Yen Chien; Yan-Ye Su; Sheng-Dean Luo; Shau-Hsuan Li
Journal:  PeerJ       Date:  2022-07-13       Impact factor: 3.061

5.  The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines.

Authors:  Darren Chyi-Hsiang Kong; Kenneth Yee Choy Chew; Eng Lai Tan; Suan Phaik Khoo
Journal:  Cancer Cell Int       Date:  2014-11-18       Impact factor: 5.722

6.  Interdependence of antioxidants and micronutrients in oral cancer and potentially malignant oral disorders: a serum and saliva study.

Authors:  Shishir Ram Shetty; Subhas G Babu; Prasanna Kumar Rao; Sham Kannepady Kishor; Kumuda Arvind Rao; Renita Castelino
Journal:  J Dent (Tehran)       Date:  2014-11-30

7.  The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.

Authors:  Minal Chaudhary; Shree Bajaj; Shruti Bohra; Nisu Swastika; Alka Hande
Journal:  J Oral Maxillofac Pathol       Date:  2015 May-Aug

8.  The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases.

Authors:  Bo Wang; Shu Zhang; Kai Yue; Xu-Dong Wang
Journal:  Chin J Cancer       Date:  2013-04-19

9.  Serum lipid profile in patients with oral cancer and oral precancerous conditions.

Authors:  Rajul Mehta; Shubha Gurudath; Sujatha Dayansoor; Anuradha Pai; K S Ganapathy
Journal:  Dent Res J (Isfahan)       Date:  2014-05

10.  Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer.

Authors:  Alhadi Almangush; Ibrahim O Bello; Harri Keski-Säntti; Laura K Mäkinen; Joonas H Kauppila; Matti Pukkila; Jaana Hagström; Jussi Laranne; Satu Tommola; Outi Nieminen; Ylermi Soini; Veli-Matti Kosma; Petri Koivunen; Reidar Grénman; Ilmo Leivo; Tuula Salo
Journal:  Head Neck       Date:  2013-09-02       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.